Kezar Life Sciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for KZR, updated each market day.
KZR AI Sentiment
AI sees no strong directional signal for Kezar Life Sciences, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Kezar Life Sciences, Inc. Common Stock
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Sector
Exchange
Market Cap
$54,180,723
Cap Tier
Employees
9
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
June 21, 2018
KZR Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
KZR Volatility
Kezar Life Sciences, Inc. Common Stock has shown low price volatility over the last 5 trading days. Low volatility suggests steady price action with smaller daily moves.
